22 min listen
Could a new vaccine tackle rising rates of Lyme disease?
FromScience Weekly
ratings:
Length:
16 minutes
Released:
Sep 8, 2022
Format:
Podcast episode
Description
According to a recent study, more than 14% of the world’s population probably has, or has had, tick-borne Lyme disease – an infection that can cause long and debilitating symptoms. That number is set to rise too, as climate and environment changes continue to increase tick populations and distribution. To help prevent some of these cases, pharmaceutical company Pfizer and biotech company Valneva will soon be testing a new vaccine against Lyme disease with 6,000 volunteers across Europe and in the US. Madeleine Finlay speaks to Dr Eoin Healy about what Lyme disease is and how the vaccine works, and hears from a special guest about their own experience of getting ill with the disease.. Help support our independent journalism at theguardian.com/sciencepod
Released:
Sep 8, 2022
Format:
Podcast episode
Titles in the series (100)
From the archive: Are national parks failing nature? (part 1): The climate crisis is ‘unequivocally’ caused by human activities, according to a report from the IPCC. One attempt to conserve the environment, being pushed by Boris Johnson, is to protect 30% of UK land in a boost for biodiversity. A Guardian exclusive found that an area twice the size of Greater London is devoted to grouse shooting in UK national parks, which threatens efforts to tackle the climate crisis. Patrick Greenfield and Phoebe Weston investigate whether national parks benefit the environment and biodiversity, or if there might be a better way of doing things by Science Weekly